Loading...
XASXIDT
Market cap27mUSD
Jan 10, Last price  
0.11AUD
1D
0.00%
1Q
-12.50%
Jan 2017
-41.67%
Name

IDT Australia Ltd

Chart & Performance

D1W1MN
XASX:IDT chart
P/E
—
P/S
3.36
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
7.78%
Rev. gr., 5y
1.75%
Revenues
13m
+90.71%
26,546,00024,811,00026,298,00030,871,00026,423,00011,825,00012,770,0009,808,00010,593,00013,374,00015,720,0007,610,0009,543,00013,300,00012,130,00014,102,00015,989,00012,105,0006,935,00013,226,000
Net income
-5m
L-36.30%
4,471,0003,613,0005,467,0007,110,0006,416,000-1,577,000-236,000-1,837,000-5,354,000-6,626,000-2,992,000-4,081,000-14,503,000-16,979,000-6,083,000-1,919,0002,103,000-1,160,000-8,498,000-5,413,000
CFO
-10m
L+21.51%
5,311,0004,959,0008,740,00010,329,0009,423,0003,809,0003,203,000407,000-1,182,000-1,576,000-1,786,000-2,825,0002,019,000-1,627,000-1,516,000-1,888,000370,0002,861,000-7,902,000-9,602,000
Dividend
Apr 12, 20100.0142857143 AUD/sh
Earnings
Feb 19, 2025

Profile

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. The company was founded in 1975 and is headquartered in Boronia, Australia.
URL
https://en.idtaus.com.au/
IPO date
Mar 22, 1988
Employees
156
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
13,226
90.71%
6,935
-42.71%
12,105
-24.29%
Cost of revenue
16,473
16,808
14,126
Unusual Expense (Income)
NOPBT
(3,247)
(9,873)
(2,021)
NOPBT Margin
Operating Taxes
(662)
(1,278)
(716)
Tax Rate
NOPAT
(2,585)
(8,595)
(1,305)
Net income
(5,413)
-36.30%
(8,498)
632.59%
(1,160)
-155.16%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,039
3,784
315
BB yield
-7.93%
-23.85%
-1.14%
Debt
Debt current
4,468
740
881
Long-term debt
Deferred revenue
Other long-term liabilities
173
166
314
Net debt
3,564
(3,693)
(8,333)
Cash flow
Cash from operating activities
(9,602)
(7,902)
2,861
CAPEX
(694)
(522)
(912)
Cash from investing activities
(1,094)
(522)
(912)
Cash from financing activities
6,767
3,643
337
FCF
(9,149)
(10,603)
1,867
Balance
Cash
904
4,433
9,214
Long term investments
Excess cash
243
4,086
8,609
Stockholders' equity
23,441
24,141
26,625
Invested Capital
27,839
20,961
19,211
ROIC
ROCE
EV
Common stock shares outstanding
348,222
244,056
240,822
Price
0.11
69.23%
0.07
-43.48%
0.12
-64.62%
Market cap
38,304
141.46%
15,864
-42.72%
27,695
-64.39%
EV
41,868
12,171
19,362
EBITDA
(2,322)
(8,834)
(485)
EV/EBITDA
Interest
119
Interest/NOPBT